Kim Melton King is a Managing Director at Gilead Group, whose known portfolio counts 3 companies.
Is Kim Melton King a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Managing Director at Gilead Group, whose known portfolio counts 3 companies
- Hookipa Pharma
- PenPath
- Agilis Systems
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Drug Discovery and Pharma. Startups operating in these areas may find Kim Melton King relevant.
Stage-wise, the deals at Gilead Group cluster around Growth, Seed and Series B rounds.
What the affiliated firm has backed is the closest available signal on whether Kim Melton King is worth approaching.
Colleagues at Gilead Group
Frequently asked questions
Who is Kim Melton King?
Kim Melton King is a family office investor based in St Louis, Missouri, United States, listed as Managing Director at Gilead Group. The known portfolio of that firm counts 3 companies. That portfolio belongs to the firm, not to Kim Melton King personally.
What does Kim Melton King invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kim Melton King invest at?
Gilead Group appears in Growth, Seed and Series B rounds across its known deals, and Kim Melton King is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kim Melton King listed at?
Kim Melton King is listed as Managing Director at Gilead Group. 2 other people in the database share a firm with Kim Melton King.
How do I contact Kim Melton King?
An email address, a phone number and a LinkedIn page are on file for Kim Melton King. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal